John d’Auguste is the new president of Imaging Diagnostic Systems. The former executive at GE Medical Systems and Gateway will report to Linda B. Grable, chair of the board, who previously served as the company president. The succession occurred as
John d’Auguste is the new president of Imaging Diagnostic Systems. The former executive at GE Medical Systems and Gateway will report to Linda B. Grable, chair of the board, who previously served as the company president. The succession occurred as the company prepares to move from an R&D to a revenue-producing company with the expected FDA approval of its Computed Tomography Laser Mammography system, according to Grable. The company has submitted four of the five modules required by the FDA. Subsequent to these personnel changes, it announced the death Aug. 13 of cofounder Richard J. Grable, who served as CEO and director of R&D. His wife has been appointed CEO.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.